Drive-the-doctor paradigm in acute ischaemic stroke for improving regional stroke care networks: a cost-effectiveness analysis
- PMID: 40157729
- PMCID: PMC11956349
- DOI: 10.1136/bmjopen-2024-091413
Drive-the-doctor paradigm in acute ischaemic stroke for improving regional stroke care networks: a cost-effectiveness analysis
Abstract
Background and objective: In a drive-the-doctor (DD) paradigm, an interventionalist travels from a comprehensive stroke centre (CSC) to primary stroke centres (PSCs) to perform endovascular thrombectomy (EVT) for acute ischaemic stroke due to large vessel occlusion (LVO). The DD paradigm may reduce time delays from onset to recanalisation. This study aimed to analyse the cost-effectiveness of the DD paradigm versus a drip-and-ship (DS) paradigm, where LVO patients are transferred from PSCs to a CSC for EVT in the northern Netherlands.
Design: Economic evaluation was performed using a simulation model combined with a decision tree and a Markov model.
Setting: Stroke centres in the northern Netherlands.
Participants: A hypothetical cohort of 100 000 LVO patients with an average age of 70 years.
Interventions: Two strategies were tested, including the DD paradigm with one upgraded PSC and the DD paradigm with two upgraded PSCs.
Main outcome measures: Total costs and quality-adjusted life years (QALYs) were measured over a 15-year time horizon from a Dutch healthcare provider perspective. An incremental cost-effectiveness ratio (ICER) of €50 000 was used as a willingness-to-pay threshold. One-way sensitivity, probabilistic sensitivity and scenario analyses (interventionalist transportation by car, ambulance and helicopter) were conducted to examine parameter uncertainty.
Results: The DD paradigm using car as a transport modality and two PSCs was the optimal strategy, resulting in the lowest ICER. This strategy provided an additional 0.13 QALYs at incremental costs of €2367, yielding an ICER of €18 306 compared with current practice. The DD paradigm with two PSCs reduced ICERs compared with the scenario with one PSC when varying transportation modalities (car, ambulance and helicopter). Probabilistic sensitivity analyses showed that the DD paradigm with two PSCs using car was preferred in 72% of 10 000 Monte Carlo simulations.
Conclusions: The DD paradigm appeared cost-effective for LVO patients and may be considered a promising evolution for a regional stroke network.
Keywords: HEALTH ECONOMICS; Organisation of health services; Stroke.
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
Conflict of interest statement
Competing interests: EB reports funding from the Netherlands Heart Foundation and a Public Private Partnership allowance from Health Holland, ZonMw and NOW. EB serves at ZonMw committee as a (vice-) chairman, at ZuidOost Zorg and 113 Suicide Prevention as a member advisory board. MU has received research grants from ZonMw and Dutch Heart Foundation. DJVDZ is a member of the supervisory board Radiotherapeutisch Instituut Friesland.
Figures


Similar articles
-
'Drive the doctor' for endovascular thrombectomy in a rural area: a simulation study.BMC Health Serv Res. 2023 Jul 20;23(1):778. doi: 10.1186/s12913-023-09672-5. BMC Health Serv Res. 2023. PMID: 37475023 Free PMC article.
-
Cost-effectiveness of endovascular treatment after 6-24 h in ischaemic stroke patients with collateral flow on CT-angiography: A model-based economic evaluation of the MR CLEAN-LATE trial.Eur Stroke J. 2024 Jun;9(2):348-355. doi: 10.1177/23969873231220464. Epub 2023 Dec 28. Eur Stroke J. 2024. PMID: 38153049 Free PMC article.
-
Costs and health effects of CT perfusion-based selection for endovascular thrombectomy within 6 hours of stroke onset: a model-based health economic evaluation.J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):515-527. doi: 10.1136/jnnp-2023-331862. J Neurol Neurosurg Psychiatry. 2024. PMID: 38124162
-
The economic impact associated with stent retriever selection for the treatment of acute ischemic stroke: a cost-effectiveness analysis of MASTRO I data from a Chinese healthcare system perspective.J Comp Eff Res. 2024 Nov;13(11):e240160. doi: 10.57264/cer-2024-0160. Epub 2024 Nov 5. J Comp Eff Res. 2024. PMID: 39498634 Free PMC article.
-
Cost-effectiveness analysis of endovascular treatment with or without intravenous thrombolysis in acute ischemic stroke.J Neurosurg. 2022 Jun 10;138(1):223-232. doi: 10.3171/2022.4.JNS22514. Print 2023 Jan 1. J Neurosurg. 2022. PMID: 35901768 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical